Denis Nikolov: A Call for Routine UACR Assessment in High-Risk Cardiovascular Patients
Denis Nikolov, Interventional Cardiologist shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Biomedical Journal of Scientific and Technical Research (BJSTR), adding:
”I’m pleased to share our newly published mini-review:
‘Should Cardiologists Routinely Measure the Urinary Albumin-to-Creatinine Ratio? A Mini Review’
In everyday cardiology practice, renal assessment is still often limited to serum creatinine and eGFR. However, preserved eGFR does not necessarily mean the absence of kidney damage.
Urinary albumin-to-creatinine ratio (UACR) provides complementary information and may help us:
- detect CKD despite preserved eGFR
- improve cardio-renal risk stratification
- identify high-risk patients earlier
- support timely initiation or optimization of evidence-based cardio-renal therapies
Our conclusion is straightforward: UACR should be strongly considered as part of routine assessment in cardiovascular patients at increased cardio-renal-metabolic risk, particularly those with heart failure, type 2 diabetes, arterial hypertension, or established atherosclerotic cardiovascular disease.
Proud to have worked on this together with Hristo Stoev and Petar Iliev.”
Title: Should Cardiologists Routinely Measure the Urinary Albumin-to-Creatinine Ratio? A Mini Review
Authors: Denis Nikolov, Hristo Stoev, Petar Iliev
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator